Alliancebernstein L.P. Sells 759,605 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Alliancebernstein L.P. cut its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 9.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,350,489 shares of the company's stock after selling 759,605 shares during the period. Alliancebernstein L.P. owned 8.56% of Pediatrix Medical Group worth $96,438,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Nomura Asset Management Co. Ltd. grew its stake in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the period. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares in the last quarter. Quarry LP increased its position in Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after buying an additional 1,662 shares in the last quarter. AlphaQuest LLC grew its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after acquiring an additional 2,012 shares during the last quarter. Finally, Smartleaf Asset Management LLC increased its holdings in shares of Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after acquiring an additional 6,090 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Price Performance

MD traded down $0.52 on Monday, hitting $12.99. 244,611 shares of the company's stock traded hands, compared to its average volume of 833,587. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $17.67. The company's 50 day simple moving average is $14.42 and its 200-day simple moving average is $13.82. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of -10.85, a P/E/G ratio of 1.74 and a beta of 1.32.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. As a group, research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MD. Truist Financial upped their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research note on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. UBS Group increased their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Finally, Macquarie started coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $18.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.